Capricor Therapeutics (CAPR) EPS (Basic) (2010 - 2026)
Capricor Therapeutics (CAPR) recorded quarterly EPS (Basic) of -$0.59 in Q1 2026, up 4.84% quarter-over-quarter from -$0.62 in Q4 2025, and down 11.32% on a YoY basis from -$0.67 in Q1 2025.
Capricor Therapeutics (CAPR) EPS (Basic) (2010 - 2026) Analysis & Trends
Capricor Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.59 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 11.32% year-over-year to -$0.59; the TTM figure through Mar 2026 stood at -$2.32 (down 69.34% YoY), while the FY2025 annual figure was -$2.26, down 96.52% from the prior year.
- EPS (Basic) was -$0.59 for Q1 2026 at Capricor Therapeutics, up from -$0.62 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.02 in Q4 2023 to a low of -$0.62 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.35 across 5 years, with a median of -$0.31 in 2023.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) soared 106.45% in 2023, then sank 650.0% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.31 in 2022, then surged by 106.45% to $0.02 in 2023, then tumbled by 650.0% to -$0.11 in 2024, then tumbled by 463.64% to -$0.62 in 2025, then gained by 4.84% to -$0.59 in 2026.
- The last three EPS (Basic) figures came in at -$0.59 (Q1 2026), -$0.62 (Q4 2025), and -$0.54 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.06 |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | -0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.59 |
| Dec 31, 2025 | -0.62 |
| Sep 30, 2025 | -0.54 |
| Jun 30, 2025 | -0.57 |
| Mar 31, 2025 | -0.53 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -0.31 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.25 |
| Jun 30, 2023 | -0.29 |
| Mar 31, 2023 | -0.31 |
| Dec 31, 2022 | -0.31 |
| Sep 30, 2022 | -0.26 |
| Jun 30, 2022 | -0.29 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | -0.21 |